PALM SPRINGS, CALIFORNIA - iCFO Capital Global, Inc., partnered with Ventis Pharma to raise $16M in growth funding for expanding from iCFO Capital Global investor network nationwide.
Ventis Pharma is a bio-pharmaceutical company which focuses on vertical product lines that bring an assortment of new medications and solutions to drug issues in the clinical anesthesia space, the pediatric space as well as commercializing an innovative medical device for operating rooms. Ventis has additional drug development on-going, as well as a clinical partnerships with a European Pharma company. Our product diversity provides a reduced investment risk to our investors.
Their team has developed a unique strategy developing and finding drugs that allow Ventis Pharma to produce new patented combination medications that can be sold and marketed through an FDA 503B outsourcing manufacturing facility, prior to FDA new drug approval. This strategy allows them to penetrate the market, to verify proof of concept, to provide samples and to initiate sales of their three medical products while they move through the FDA approval process as fast track designated drugs.
Their extensive experience with the FDA 503B regulatory process allows them to navigate through FDA processes with great efficiency. Their costs and time-lines to get through the FDA new drug approval process are significantly shorter and less expensive with their strategies than with the conventional new drug pathways.
This makes it possible for Ventis to create a substantial client base prior to final FDA approvals, while FDA mandates their products be treated as if fully FDA approved, by the fact of their origin in FDA qualified specialty labs and per FDA direction to payors.
Meet Tim Patrick, the visionary CEO of Ventis Pharma, whose notable track record encompasses building and successfully exiting two thriving pharmaceutical startups. With a career spanning over three decades, Mr. Patrick's expertise and astute leadership have propelled him as one of the true experts in the pharmaceutical industry.
Mr. Patrick brings his exceptional leadership and unparalleled expertise to guide the company toward groundbreaking advancements in the pharmaceutical industry while delivering improved patient outcomes. With his visionary outlook, unwavering determination, and proven track record of success, Mr. Patrick continues to steer Ventis Pharma toward unprecedented achievements, cementing its position as a trailblazer in the field.
For more information about the company visit: https://www.ventispharma.com/
iCFO Capital Global, Inc. provides a platform for Entrepreneurs to connect with our Private Investors that makes direct debt and equity investment for early-stage and expand growth businesses. To learn more about how your business can secure the funding it needs, visit: https://www.icfocapital.com/
Schedchule a meeting with our General Partner, George Mena at the following link:
https://calendly.com/icfo-georgemena
